Impact of proton pump inhibitors on the onset of gastrointestinal immune-related adverse events during immunotherapy.
Angioletta LasagnaFederica MascaroSimone FiginiSara BasileGiulia GambiniCatherine KlersyMarco Vincenzo LentiAntonio Di SabatinoAlice Di BenedettoMonica CalviRaffaele BrunoPaolo SacchiPaolo PedrazzoliPublished in: Cancer medicine (2023)
Chronic PPI use is associated with an increased risk of GI irAES.